- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07901335
KLF4 Epigenetic Modulation (POLYEP)
KLF4 Epigenetic Modulation During Polyps-adenoma Progression
The study investigates the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. Quantitative KLF4 methylation will be assessed in colorectal tissue samples obtained during routine colonoscopy, together with KLF4 gene expression and its correlation with methylation status in matched tissue samples. The study will also evaluate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Colorectal cancer is one of the most frequently diagnosed cancers worldwide. Colorectal polyps and adenomas represent precursor lesions that may undergo malignant transformation. KLF4 is a transcription factor involved in the regulation of cellular processes and has been described as having context-dependent roles in cancer development. Its activity may be regulated by epigenetic mechanisms, including DNA methylation. The purpose of this prospective observational study is to investigate the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. The primary objective is to assess quantitative KLF4 methylation across different stages of colorectal tissue progression. Secondary objectives are to investigate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation and to assess KLF4 gene expression and its correlation with KLF4 methylation in matched tissue samples.
The study is monocentric and will be conducted at AUSL-IRCCS Reggio Emilia. Participants will be adults undergoing routine colonoscopy and diagnosed by the Pathology Division of AUSL-IRCCS Reggio Emilia. Only tissue samples obtained during routine diagnostic procedures and accompanied by signed informed consent will be included. The research procedures will not affect the diagnostic procedures.
Colorectal tissue samples will be processed as formalin-fixed, paraffin-embedded (FFPE) sections. Genomic DNA and total RNA will be extracted from the samples. DNA methylation will be assessed following bisulfite conversion and specific bisulfite PCR using quantitative PCR approaches. KLF4 gene expression will be assessed by real-time quantitative PCR. Molecular data will be recorded in a study database.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studieorter
-
-
-
Reggio Emilia, Italien
- Rekrytering
- Azienda USL IRCCS di Reggio Emilia
-
Kontakt:
- Raffaele Frazzi, PhD
- Telefonnummer: 0522 295777
- E-post: raffaele.frazzi@ausl.re.it
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
The samples are represented by endoscopic specimens collected only during routine exams.
Beskrivning
Inclusion Criteria:
- Patients undergoing routine colonoscopy
- > 18 years of age
- Diagnosed by S.C. Anatomia Patologica, AUSL-IRCCS Reggio Emilia
Exclusion Criteria:
- Concomitant diagnosis of colorectal carcinoma
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
KLF4 DNA methylation
Tidsram: 24 months
|
Quantitative assessment of KLF4 DNA methylation in colorectal tissue samples representing different stages of colorectal polyp-adenoma-carcinoma progression. KLF4 methylation will be assessed using bisulfite conversion followed by specific PCR. |
24 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Site-specific KLF4 methylation
Tidsram: 24 months
|
Evaluation of site-specific KLF4 DNA methylation in colorectal tissue samples using molecular approaches based on bisulfite conversion and PCR analysis. |
24 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 340/2026/TESS/IRCCSRE
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .